Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison

Background - Total neoadjuvant treatment (TNT) has been increasingly adopted for multimodal rectal cancer treatment. Here, we present the 5-year results of our CAO/ARO/AIO-12 randomized phase II trial that compared two TNT sequences. - Patients and methods - Patients were initially randomized 1 : 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Diefenhardt, Markus (VerfasserIn) , Kosmala, R. (VerfasserIn) , Fleischmann, M. (VerfasserIn) , Martin, D. (VerfasserIn) , Hofheinz, Ralf-Dieter (VerfasserIn) , Ghadimi, M. (VerfasserIn) , Rödel, Claus (VerfasserIn) , Polat, B. (VerfasserIn) , Fokas, Emmanouil (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 2025
In: ESMO open
Year: 2025, Jahrgang: 10, Heft: 3, Pages: 1-10
ISSN:2059-7029
DOI:10.1016/j.esmoop.2025.104483
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.esmoop.2025.104483
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2059702925003527
Volltext
Verfasserangaben:M. Diefenhardt, R. Kosmala, M. Fleischmann, D. Martin, R.-D. Hofheinz, M. Ghadimi, C. Rödel, B. Polat & E. Fokas

MARC

LEADER 00000caa a2200000 c 4500
001 1931582998
003 DE-627
005 20250911223523.0
007 cr uuu---uuuuu
008 250723s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.esmoop.2025.104483  |2 doi 
035 |a (DE-627)1931582998 
035 |a (DE-599)KXP1931582998 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Diefenhardt, Markus  |d 1991-  |e VerfasserIn  |0 (DE-588)1139869779  |0 (DE-627)897777530  |0 (DE-576)493515747  |4 aut 
245 1 0 |a Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer  |b 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison  |c M. Diefenhardt, R. Kosmala, M. Fleischmann, D. Martin, R.-D. Hofheinz, M. Ghadimi, C. Rödel, B. Polat & E. Fokas 
264 1 |c March 2025 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 7. März 2025, Artikelversion: 7. März 2025 
500 |a Gesehen am 23.07.2025 
520 |a Background - Total neoadjuvant treatment (TNT) has been increasingly adopted for multimodal rectal cancer treatment. Here, we present the 5-year results of our CAO/ARO/AIO-12 randomized phase II trial that compared two TNT sequences. - Patients and methods - Patients were initially randomized 1 : 1 to arm A (induction chemotherapy followed by chemoradiotherapy) or arm B (chemoradiotherapy followed by consolidation chemotherapy) followed by total mesorectal excision surgery. This report on the 5-year results involved a general pairwise comparison (GPC) of the following parameters, ranked as indicated: overall survival, incidence of locoregional recurrence, incidence of distant metastasis, rate of pathological/clinical complete remission, long-term quality of life (at least 24 months after randomization) based on global health assessed by the European Organisation For Research And Treatment Of Cancer Quality of Life Questionnaire Core 30 questionnaire, and incidence of toxicity, ranked by grade, during follow-up. - Results - A total of 306 patients were eligible for this analysis. After a median follow-up of 60 months (interquartile range 58-62 months), we found that long-term oncological outcome was comparable in both arms [e.g. 5-year overall survival 85.8% (95% confidence interval 80.2% to 91.8%) in arm A and 84.2% (95% confidence interval 78.2% to 90.5%) in arm B], regardless of whether patients received induction chemotherapy and chemoradiotherapy or chemoradiotherapy and consolidation chemotherapy. The GPC showed no clinically meaningful overall treatment benefit (−1.38%) or win ratio difference (0.97) between the two treatment sequences. The incidence of pathological or sustained clinical complete remission remained higher in patients treated with consolidation chemotherapy after adjusting for long-term outcome between both arms (11% versus 6.5%). - Conclusions - Our 5-year GPC confirmed the 3-year findings that chemoradiotherapy followed by consolidation chemotherapy resulted in higher rates of pathological complete remission without compromising oncological outcome, toxicity, or quality of life. The TNT sequence chemoradiotherapy/chemotherapy may be preferred for organ preservation strategies. 
650 4 |a clinical trial 
650 4 |a general pairwise comparison 
650 4 |a radiotherapy 
650 4 |a rectal cancer 
650 4 |a total neoadjuvant treatment 
700 1 |a Kosmala, R.  |e VerfasserIn  |4 aut 
700 1 |a Fleischmann, M.  |e VerfasserIn  |4 aut 
700 1 |a Martin, D.  |e VerfasserIn  |4 aut 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
700 1 |a Ghadimi, M.  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Rödel, Claus  |d 1966-  |e VerfasserIn  |0 (DE-588)1152978330  |0 (DE-627)101434705X  |0 (DE-576)499988248  |4 aut 
700 1 |a Polat, B.  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Fokas, Emmanouil  |e VerfasserIn  |0 (DE-588)136236502  |0 (DE-627)578118963  |0 (DE-576)300913397  |4 aut 
773 0 8 |i Enthalten in  |t ESMO open  |d [London] : Elsevier, 2016  |g 10(2025), 3, Artikel-ID 104483, Seite 1-10  |h Online-Ressource  |w (DE-627)84705344X  |w (DE-600)2844985-X  |w (DE-576)454658516  |x 2059-7029  |7 nnas  |a Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison 
773 1 8 |g volume:10  |g year:2025  |g number:3  |g elocationid:104483  |g pages:1-10  |g extent:10  |a Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison 
856 4 0 |u https://doi.org/10.1016/j.esmoop.2025.104483  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2059702925003527  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250901  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20250901  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20250723 
993 |a Article 
994 |a 2025 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 5 
999 |a KXP-PPN1931582998  |e 474907005X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer","title":"Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer","subtitle":"5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison"}],"name":{"displayForm":["M. Diefenhardt, R. Kosmala, M. Fleischmann, D. Martin, R.-D. Hofheinz, M. Ghadimi, C. Rödel, B. Polat & E. Fokas"]},"person":[{"given":"Markus","role":"aut","display":"Diefenhardt, Markus","family":"Diefenhardt"},{"family":"Kosmala","given":"R.","role":"aut","display":"Kosmala, R."},{"family":"Fleischmann","display":"Fleischmann, M.","role":"aut","given":"M."},{"family":"Martin","display":"Martin, D.","given":"D.","role":"aut"},{"role":"aut","given":"Ralf-Dieter","display":"Hofheinz, Ralf-Dieter","family":"Hofheinz"},{"family":"Ghadimi","role":"aut","given":"M.","display":"Ghadimi, M."},{"display":"Rödel, Claus","given":"Claus","role":"aut","family":"Rödel"},{"family":"Polat","display":"Polat, B.","given":"B.","role":"aut"},{"display":"Fokas, Emmanouil","role":"aut","given":"Emmanouil","family":"Fokas"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"March 2025"}],"recId":"1931582998","note":["Online verfügbar: 7. März 2025, Artikelversion: 7. März 2025","Gesehen am 23.07.2025"],"relHost":[{"name":{"displayForm":["European Society for Medical Oncology"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"2016","publisher":"Elsevier ; BMJ","dateIssuedDisp":"2016-","publisherPlace":"[London] ; London"}],"recId":"84705344X","disp":"Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparisonESMO open","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["84705344X"],"zdb":["2844985-X"],"issn":["2059-7029"]},"note":["Gesehen am 13.06.24"],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"title":[{"title_sort":"ESMO open","subtitle":"cancer horizons","title":"ESMO open"}],"part":{"issue":"3","extent":"10","pages":"1-10","volume":"10","year":"2025","text":"10(2025), 3, Artikel-ID 104483, Seite 1-10"},"language":["eng"],"pubHistory":["1.2016 -"]}],"id":{"eki":["1931582998"],"doi":["10.1016/j.esmoop.2025.104483"]},"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}]} 
SRT |a DIEFENHARDCHEMOTHERA2025